Protocolo de diagnóstico y seguimiento de los pacientes con fibrosis quística

Agüero, M.I. Barrio Gómez de; Hernández, G. García; Gartner, Sílvia

doi:10.1016/j.anpedi.2009.06.020

Cited by 25 publications

(19 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We included subjects diagnosed with CF who were Ն 18 y, followed up in a specialized CF unit in Madrid, Spain. 12,13 Inclusion criteria were clinical stability during the previous 4 weeks (ie, no exacerbations requiring treatment modification or hospital admission), the ability to understand and comply with the procedures, and the ability to give informed consent. The research protocol was approved by the Ethics Committee, and all participants provided written informed consent.…”

Section: Methodsmentioning

confidence: 99%

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

et al. 2018

View full text Add to dashboard Cite

BACKGROUND: Nocturnal desaturation in cystic fibrosis (CF) may have prognostic implications because a significant and maintained nocturnal desaturation can contribute to the development and progression of pulmonary hypertension with cor pulmonale. Its relation with the desaturation in exercise has not been sufficiently studied. We aimed to determine whether desaturation during 6MWT can be an indicator of nocturnal desaturation in adult subjects with CF. METHODS: 57 subjects were included: 50.9% male, 27.5 ؎ 7.7 y old, mean FEV 1 ‫؍‬ 2.37 ؎ 0.74 L, and %FEV 1 67 ؎ 18.1%. Desaturation during 6MWT was defined as oxygen saturation (S pO 2) < 90% or a decline of > 4 points in S pO 2 from baseline, and nocturnal desaturation as a desaturation index > 4 or > 5% of sleep time with S pO 2 < 90%. RESULTS: Desaturation observed during 6MWT in adult subjects with CF did not correlate with nocturnal desaturation (P ‫؍‬ .27). Subjects with %FEV 1 < 55% and diffusion capacity of carbon monoxide (D LCO) < 50 mmol/min/mm Hg were at higher risk of 6MWT desaturation. Nocturnal desaturation was more frequent in males, with P aO 2 < 71 mm Hg in blood gas analysis. CONCLUSIONS: Desaturation observed in 6MWT cannot predict desaturation at night in adults with CF. Other parameters were identified as predictors of desaturation.

show abstract

Section: Methodsmentioning

confidence: 99%

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

et al. 2018

View full text Add to dashboard Cite

show abstract

“…La literatura indica que no hay diferencia significativa entre una dieta de proteínas vegetales o de animales, por lo que una combinación de ambas es ideal (Barrio Gómez de Agüe-ro, García-Hernández y Gartner, 2009;Smirnova, Barilo y Smolnikova, 2016). La ingesta de lácteos también favorece la disminución de esta alteración, aunque las grasas saturadas de otros alimentos estén contraindicadas (Di Micco y cols., 2013).…”

Section: Discusión Y Conclusiónunclassified

Paciente con síndrome metabólico

Collado¹,

Cervera‐Gasch²

2017

AgoraSalut

View full text Add to dashboard Cite

Paciente con síndrome metabólico mAríA moreno collAdo al316134@uji.es águedA cerVerA gAsch cerveraa@uji.es resumen introducción: El síndrome metabólico es el conjunto de patologías que generan riesgo de desarrollar una enfermedad cardiaca o diabetes mellitus tipo 2. El objetivo de la intervención es mejorar la calidad de vida potenciando las medidas higiénico-dietéticas y realizar intervenciones para paliar las complicaciones derivadas por las diferentes patologías metabólicas. metodología: Se desarrolla un caso clínico basado en una paciente de 81 años que sufre diabetes mellitus tipo 2 y enfermedad cardiovascular debido a un síndrome metabólico, caracterizado por hipertensión arterial, glucemia elevada en sangre, niveles sanguíneos de triglicéridos elevados, bajos niveles de hdl y exceso de grasa central. Se realizan diferentes escalas de enfermería y pruebas analíticas para valorar el estado de la paciente tanto físico como psíquico. Se realiza la valoración con las escalas de Morisky-Green Levine, Pfeiffer, Barber, Barthel y ApgAr familiar, también se solicita un análisis y toma de constantes y glucemia de tres sesiones. resultados: Se crea un plan de intervención modificando la dieta y el ejercicio físico basado en una búsqueda de la mejor evidencia disponible en la base de datos PubMed. discusión: Nuestras acciones van dirigidas a que la paciente mejore su estado de salud intentando conseguir una disminución de la glucemia y una disminución de peso y perímetro abdominal para evitar estar en sobrepeso y la posibilidad de complicar su enfermedad cardiovascular. Estas intervenciones pueden mejorarse modificando su dieta y su actividad física diaria.palabras clave: síndrome metabólico, cuidados de enfermería, prevención, dieta, ejercicio físico. Abstract introduction:Metabolic syndrome is a set of conditions that creates a risk of developing heart disease or diabetes mellitus type II. The aim was to improve quality of life by enhancing hygiene and diet measures and interventions to alleviate any complications arising from different metabolic diseases. methodology: A case was developed based on an 81-year-old patient with diabetes mellitus type II and cardiovascular disease due to metabolic syndrome characterised by high blood pressure, high blood glucose, blood levels of triglycerides, low HDL levels and excess abdominal fat. Different nursing scales and laboratory tests were performed to assess the patient's physical and mental state.

show abstract

“…The 2009 Spanish consensus recommends oral ciprofloxacin (15–20 mg/kg/12 hours ×21 days) and inhaled tobramycin or colistin, even when no signs of infection are present. 45 If positive cultures persist after 1 month, inhalation therapy can be maintained and a new cycle of oral ciprofloxacin can be started (21 days or 30 days). If the cultures do not become negative after 1 month or 2 months, a new 14-day cycle of intravenous antibiotic should be started.…”

Section: Indication For Aerosolized Antibioticsmentioning

confidence: 99%

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

Vázquez-Espinosa

Girón

Gómez-Punter

et al. 2015

TCRM

View full text Add to dashboard Cite

Cystic fibrosis (CF) is a fatal inherited disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene whose mortality is conditioned by a progressive decline in lung function. Bacterial infections play a key role in this decline. Chronic bacterial infection in CF patients varies over time and the presence of Pseudomonas aeruginosa in sputum is a marker of poor prognosis. P. aeruginosa is eradicated from the airways using inhaled antibiotics administered in various formulations and devices. Antipseudomonal antibiotics have extended the survival of CF patients to 40 years. Tobramycin is a bactericidal aminoglycoside antibiotic with demonstrated activity against gram-negative microorganisms. Initially, the drug was administered as an inhaled parenteral solution. Subsequently, a specific tobramycin inhalation solution was developed. PulmoSphere™ technology enables dry tobramycin powder to be formulated for inhalation (tobramycin inhalation powder) using a small and portable capsule-based breath-activated device (T-326). Chronic colonization by P. aeruginosa is the main indication for aerosol antibiotic therapy. The American Cystic Fibrosis Foundation, European guidelines, and Spanish consensus guidelines provide different recommendations for eradication.

show abstract

Protocolo de diagnóstico y seguimiento de los pacientes con fibrosis quística

Cited by 25 publications

References 32 publications

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

Paciente con síndrome metabólico

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

Contact Info

Product

Resources

About

Protocolo de diagnóstico y seguimiento de los pacientes con fibrosis quística

Cited by 25 publications

References 32 publications

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis

Paciente con síndrome metabólico

Long-term safety and efficacy of tobramycin in the&nbsp;management of cystic fibrosis

Contact Info

Product

Resources

About

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis